Фото: РИА Новости
根据公告，此次收购存在显著溢价。截至2025年10月31日，南大药业所有者权益约2亿元，而根据中盛评估咨询资产评估报告，股东全部权益评估值高达5.85亿元，评估增值率约192.5%，对应22.2324%股权的收购价为1.3亿元。
，详情可参考体育直播
Последние новости
Tuttle’s position came under threat after an awards gala at the end of the 76th edition last month, in which several prize winners condemned Israel’s actions against Palestinians from the stage.